BioCentury
ARTICLE | Clinical News

Topical prostaglandin E1 gel: MCHM will begin a 60 patient Phase I/II dose-escalating trial

March 11, 1996 8:00 AM UTC

MacroChem Corp. (MCHM), Lexington, Mass. Product: Topical prostaglandin E1 gel Indication: Erectile dysfunction Status: MCHM will begin a 60 patient Phase I/II dose-escalating trial of its topical gel...